Epigenome-wide differential methylation and differential variability as predictors of high-grade cervical intraepithelial neoplasia (CIN2+)AMERICAN JOURNAL OF EPIDEMIOLOGYIF4.82024-08-080PRE
Stakeholder perspectives of the multi-level barriers to treatment among rural endometrial cancer patients: A qualitative studyCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42023-12-010PRE
Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United StatesBMC CANCERIF3.42023-11-064OAAI
Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancerJOURNAL OF GERIATRIC ONCOLOGYIF2.72023-01-010OA
Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United StatesCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42022-06-025OA
Adverse Urinary System Diagnoses among Older Women with Endometrial CancerCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42022-05-110OA
Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and ReportingRADIOLOGYIF15.22019-11-0144PREAI
Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer PatientsCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42019-05-0322OAAI
DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesionsINTERNATIONAL JOURNAL OF CANCERIF4.72018-03-3011OAAI
A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group StudyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52017-12-0122PREAI
Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured womenAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYIF8.42016-10-0116OAAI
The effects of NT-1044, a novel AMPK activator, on endometrial cancer cell proliferation, apoptosis, cell stress, and tumor growthCANCER RESEARCHIF16.62016-07-150PRE
Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)NATURE GENETICSIF31.82016-01-012OAAI
Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian CancerOBSTETRICS AND GYNECOLOGYIF4.72015-12-0126PREAI
The effects of NT-1044, a novel AMPK activator, on endometrial cancer cell proliferation and apoptosisCANCER RESEARCHIF16.62015-08-010PRE
Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal PharmacologyJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82013-12-0168OAAI
Relationship between serum hormone levels and pharmacokinetics (PK) of PEGylated liposomal doxorubicin (PLD) in patients with refractory ovarian cancerCANCER RESEARCHIF16.62012-04-011PRE
Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et alAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYIF8.42012-03-010OA
Disparities in the Allocation of Treatment in Advanced Ovarian Cancer Are There Certain Patient Characteristics Associated With Nonstandard Therapy?OBSTETRICS AND GYNECOLOGYIF4.72012-01-0139PREAI